The demand for weight-loss drugs like Ozempic and Zepbound has surged, leading to shortages and a race to develop next-generation medications. Eli Lilly's Zepbound is facing supply issues due to high demand, with Eli Lilly warning patients may leave pharmacies empty-handed, while Viking's oral obesity medicine shows promise with a 3.3% placebo-adjusted average weight loss and no safety concerns. The success of these drugs is not only reshaping the market but also the narrative around obesity, framing it as a chronic disease rather than a cosmetic condition. This shift is accompanied by a significant development effort, with almost 100 new drugs aiming for improvements in ease of use, side effects, and efficacy. However, up to 15% of users see little to no weight loss, highlighting the continued importance of diet and exercise. The conversation around these drugs also touches on broader societal issues, including implicit biases and the language used to discuss weight.
Diab*tes: A Stigmatizing Expression of Sugar Phobia via @ConscienHealth https://t.co/VeUZGAFNYP
The "Oatzempic" craze is picking up steam on social media. Some claim the mix of oats, lime, water and a sprinkle of cinnamon blended into a meal-replacement drink can help mimic the benefits of weight loss drugs. @RhiannonAlly has more on the trend. https://t.co/JGZdFedvAK
The success of anti-obesity drugs is driving efforts to frame obesity as a chronic disease rather than a cosmetic condition. For instance, a person isn't "overweight," they "have overweight." A person isn't "obese," they "have obesity." https://t.co/yxWOKa9FHT
Don't say "obese": America's changing language around weight https://t.co/VzMTqBHoF4 @TreedinDC
The race to develop the next generation of weight-loss drugs: “We are looking at a new era where it’s possible to treat obesity in the same way it’s been possible to treat high blood pressure,” https://t.co/wBib0TJHBJ
#weight related sterotypes in a GLP-1 world @IntJObesity https://t.co/G5DtH3gVcm
According to the WSJ, up to 15% of people who take Ozempic & Wegovy see little to no weight loss due to genetics, etc. $NVO $LLY Looks like diet and exercise is still the universal solution...
The race to develop the next generation of weight-loss drugs https://t.co/lQW2RUG2ss
Demand for weight-loss drugs is surging. Blockbuster medicines like Ozempic have spurred the development of almost 100 wannabe drugs that aim to be easier to take, cause fewer side-effects or deliver more effective weight loss https://t.co/6Ri4d65m9O
Pharmacists are selling out of weight loss drugs. One told Four Corners he would buy thousands of vials if he could. Watch the #4Corners documentary 'The Ozempic Underground' tonight on ABC TV and ABC iview: https://t.co/R6TJdmaH4L https://t.co/PseJ8O1SJ8
Beyond #weightloss The emerging actions of GLP-1 medicines to tame inflammation and reduce complications #heartdisease #T2D #obesity #Alzheimers #parkinsons Will weight-loss drugs eat the world? https://t.co/SmjMnCOXFs from @TheEconomist
‘CURVY AND SOLID’: The “Pitch Perfect” star acknowledges that medications like Ozempic can be helpful, but says she ultimately chose to focus on her physical and mental health in order to lose weight. https://t.co/1HRfuzsbWW https://t.co/K8xtm8d3Bd
"Demand for weight-loss solutions is high in #China, where obesity rates among Chinese adults have more than doubled the past 2 decades...The % of adults classified as overweight & obese in 🇨🇳 reached 50.7% in 2022" https://t.co/D5DDR5yLbx
A tsunami of obesity drugs are in clinical trials 💉💊 Cc: @rtnarch @Noahpinion @PeterDiamandis @DKThomp https://t.co/qm5KCEVQ1U
Appealing Narratives Untethered from the Truth via @ConscienHealth https://t.co/vssGwrY3Zl
Appealing Narratives Untethered from the Truth https://t.co/glyqIz81kq by @ConscienHealth @GarethLeng @RhodriLeng "...the problem with prioritizing the story in a scientific work is that it engages those very biases that we have recognized as subverting the 'integrity' of…
Truthful Misinformation https://t.co/WtZnSz6fFi "Attention grabbing" and accurate anecdotes can fuel inaccurate beliefs. "Truthful misinformation may contribute to this affective polarization, by exposing us much more to the worst people on each side and less to the average…
Could weight-loss drugs eat the world? Scientists are finding that anti-obesity medicines can also help treat many other diseases https://t.co/YFIEzhcPAB
This will ring some bells with folks in the nicotine space. Appealing Narratives Untethered from the Truth - ConscienHealth https://t.co/CJ6z35O3E3
Nicotine science and policy tell me they feel seen. 😑 Appealing Narratives Untethered from the Truth - ConscienHealth https://t.co/gerJWNP5rx
Implicit Bias: “Just Be More Active to Overcome Obesity” - ConscienHealth https://t.co/UayeIjcYoG
GLP-1 Costs May Ease Restrictions to Bariatric Surgery? 🤷🏼❓ https://t.co/khwFIgH27m https://t.co/khwFIgH27m
PSA- Ozempic is the next opioid crisis. First we make everyone obese and pre-diabetic. Then we promote a miracle drug to fix it. Then Medicare funnels billions to Big Pharma, who use the $ to bribe doctors and regulatory agencies. Rinse, repeat. Huge target market. Beware. https://t.co/3vKwoS4PNa
We’re seeing all this Ozempic discussion popping up on the timeline again. Everyone is saying it’s a miracle drug. We still hold the belief that weight loss should be earned. There’s a joy in fitness and earning strength and learning how to manipulate your body with food. By…
Viking said its oral obesity medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues. https://t.co/zMHPmQZ30t
Demand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed. https://t.co/zKiXBtWfp9
Le Roux's group speculates about the next phase of GLP-1RA research: how the drugs will impact food preference and eating behavior, which has major implications for Big Industry. https://t.co/NGDroVehJD